Tasly Pharmaceutical Group Co., Ltd — Biomedical Watch V2

Traitements7programmes

Essais3liés

Publications0liées

SourceDBlocale

Traitements

7

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
High dose QiShen YiQi Dripping Pills 3 bagsThis study will evaluate the efficacy and safety and the best effective dose of QiShen YiQi Dripping Pills in the treatment of chronic heart failure with decreased ejection fraction of CHD (Qi deficiency and blood stasis syndrome).	Insuffisance cardiaque	Phase 2	À vérifier	China	À vérifier
Low dose QiShen YiQi Dripping Pills 3 bagsThis study will evaluate the efficacy and safety and the best effective dose of QiShen YiQi Dripping Pills in the treatment of chronic heart failure with decreased ejection fraction of CHD (Qi deficiency and blood stasis syndrome).	Insuffisance cardiaque	Phase 2	À vérifier	China	À vérifier
Qishen Yiqi Dripping Pills 2 bagsThis trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted from Coronary Heart Disease (Syndrome of Qi Deficiency with Blood Stasis).	Insuffisance cardiaque, Maladie coronarienne	Phase 3	À vérifier	China	À vérifier
Qishen Yiqi dripping pills 4 bags/timeMain objective: To evaluate the efficacy, safety and clinical dose exploration of Qishen Yiqi dripping pills in the treatment of chronic heart failure with preserved ejection fraction.	Insuffisance cardiaque	Phase 2	À vérifier	China	À vérifier
Qishen Yiqi Dripping Pills 2 bagsThis trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted from Coronary Heart Disease (Syndrome of Qi Deficiency with Blood Stasis).	Insuffisance cardiaque	Phase 3	À vérifier	China	À vérifier
Low dose QiShen YiQi Dripping Pills 3 bagsThis study will evaluate the efficacy and safety and the best effective dose of QiShen YiQi Dripping Pills in the treatment of chronic heart failure with decreased ejection fraction of CHD (Qi deficiency and blood stasis syndrome).	Insuffisance cardiaque	Phase 2	À vérifier	China	À vérifier
Qishen Yiqi dripping pills 4 bags/timeMain objective: To evaluate the efficacy, safety and clinical dose exploration of Qishen Yiqi dripping pills in the treatment of chronic heart failure with preserved ejection fraction.	Insuffisance cardiaque	Phase 2	À vérifier	China	À vérifier

Essais cliniques

3

Molécule	Indication / population	Phase	NCT	Titre	Statut
Qishen Yiqi dripping pills 4 bags/time	Insuffisance cardiaque	Phase 2	NCT04944706	Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction	COMPLETED
Low dose QiShen YiQi Dripping Pills 3 bags	Insuffisance cardiaque	Phase 2	NCT04983043	Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure	COMPLETED
Qishen Yiqi Dripping Pills 2 bags	Insuffisance cardiaque	Phase 3	NCT07687186	Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.